MXiPr
Aliases: Mxip, Isopropyxetamine, 3-meo-2-oxo-pcipr, Isopropyloxetamine, 3-methoxy-2-oxo-pcipr
Categories
Summary
Potency is highly batch-variable; accurate milligram-scale weighing and reagent testing strongly recommended. Early batches reported impurities with distinct odors. Users frequently report impaired motor control, derealisation, and potential for mania or psychosis at higher doses. Anecdotal reports suggest higher risk of rhabdomyolysis and seizures compared to similar dissociatives. Safe setting and sober supervision advised.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 10-20mg | 20-40mg | 40-60mg | 60mg+ |
| Insufflated | 10-20mg | 20-40mg | 40-60mg | 60mg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects |
|---|---|---|---|---|---|
| Oral | 15-45 min | 30-60 min | 0.75-2.0 hrs | 1.0-2.0 hrs | 1.0-3.0 hrs |
| Insufflated | 4-15 min | 15-30 min | 45-90 min | 1.0-2.0 hrs | 1.0-3.0 hrs |
Tolerance
Build-up
develops with repeated use over days to weeks
Reset
2–4 weeks for noticeable reduction
Cross-tolerance
Effects
Positive
- Stimulation
- Pain Relief
- Physical euphoria
- Pain relief
- Analgesia
Negative
- Numbness
- Loss of balance
- Nausea
- Sedation
- Physical disconnection
Positive
- Euphoria
- Conceptual Thinking
Negative
- Depersonalization
- Derealization
- Motor Control Loss
- Amnesia
- Mania
- Motor control loss
- Time Distortion
- Time distortion
Positive
- Perception of Bodily Lightness
- Increased Music Appreciation
Negative
- Tactile Suppression
- Spatial Disorientation
- Disinhibition
- Tactile suppression
- Visual Disconnection
- Internal Hallucinations
- Visual disconnection
- Auditory distortion